Coeptis Therapeutics Holdings Inc (NASDAQ:COEP) has a beta value of -0.90 and has seen 0.8 million shares traded in the recent trading session. The COEP stock price is -361.9% off its 52-week high price of $0.97 and 28.57% above the 52-week low of $0.15. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.86 million shares traded. The 3-month trading volume is 429.67K shares.
Coeptis Therapeutics Holdings Inc (NASDAQ:COEP) trade information
Sporting 0.57% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the COEP stock price touched $0.21 or saw a rise of 11.76%. Year-to-date, Coeptis Therapeutics Holdings Inc shares have moved -72.93%, while the 5-day performance has seen it change 14.95%. Over the past 30 days, the shares of Coeptis Therapeutics Holdings Inc (NASDAQ:COEP) have changed 8.27%. Short interest in the company has seen 0.15 million shares shorted with days to cover at 0.4.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Coeptis Therapeutics Holdings Inc (COEP) estimates and forecasts
The company’s shares have lost -28.31% over the past 6 months, compared to 17.30% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -311.69% over the past 5 years.
COEP Dividends
Coeptis Therapeutics Holdings Inc is expected to release its next earnings report in January this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Coeptis Therapeutics Holdings Inc (NASDAQ:COEP)’s Major holders
Insiders own 18.53% of the company shares, while shares held by institutions stand at 4.28% with a share float percentage of 5.25%. Investors are also buoyed by the number of investors in a company, with Coeptis Therapeutics Holdings Inc having a total of 17.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. As of Sep 30, 2024, the former fund manager holds about 0.25% shares in the company for having 100.76 shares of worth $20464.0 while later fund manager owns 99.3 shares of worth $20168.0 as of Oct 31, 2024, which makes it owner of about 0.24% of company’s outstanding stock.
